Listed in the December 27, 2023 extract; not in the current extract (September 22, 2026): Minitran (02163527), Minitran (02163535). Source: odb-formulary-ed43-extract-2023-12-27.xml; compared with odb-formulary-ed43-extract-2026-09-22.xml.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Nitroglycerin
Form:
20 of 20 products shown
13 general benefit · 5 not a benefit · 2 listing conditions apply
Nitrostat · DIN 00037613 · 0.3 mg · SL tablet
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
No interchangeable product listed in the Ontario extract
Nitrostat · DIN 00037613
Manufacturer: Upjohn Canada ULC; listing date 1996-10-01
Health Canada: Marketed since 2023-08-03 · brand NITROSTAT · ATC C01DA02 GLYCERYL TRINITRATE · form Tablet · route Sublingual · ingredients NITROGLYCERIN 0.3 MG · company Bgp pharma ulc · schedule Ethical
DIN 00037613: Nitrostat
Raw flags: sec3=Y
Item: 241200004; group id 369; item number 0864; lccId None; manufacturer id UJC
Source form: SL Tab; strength: 0.3mg
Recorded listing: General benefit
Source prices (unrounded): $0.1888; ministry $0.1888
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00037613
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=1254
Shortage status: resolved shortage (ended May 29, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=00037613
Shortage record checked October 6, 2026
Trinipatch 0.4 · DIN 02230733 · 0.4 mg/Hr/14 Sq Cm · Patch
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
No interchangeable product listed in the Ontario extract
Trinipatch 0.4 · DIN 02230733
Manufacturer: Knight Therapeutics Inc.; listing date 1999-04-15
Health Canada: Marketed since 2026-02-02 · brand TRINIPATCH 0.4 · ATC C01DA02 GLYCERYL TRINITRATE · form Patch · route Transdermal · ingredients NITROGLYCERIN 0.4 MG/HOUR · company Knight therapeutics inc. · schedule Ethical
Trinipatch 0.4: Formulary list price $0.90 per unit (the source does not state the unit; exact figure $0.8950). What the ministry pays, not the patient.
DIN 02230733: Trinipatch 0.4
Raw flags: sec3=Y
Item: 241200067; group id 369; item number 0862; lccId None; manufacturer id KNT
Source form: Patch; strength: 0.4mg/Hr/14 Sq Cm
Recorded listing: General benefit
Source prices (unrounded): $0.8950; ministry $0.8950
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02230733
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=49995
Shortage status: resolved shortage (ended February 7, 2024); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02230733
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
1 brand, same coverage
Nitrolingual Pump Spray · DIN 02231441
Manufacturer: Sanofi Aventis Pharma; listing date 1999-04-15
Health Canada: Marketed since 2026-07-16 · brand NITROLINGUAL PUMPSPRAY · ATC C01DA02 GLYCERYL TRINITRATE · form Metered-dose pump · route Sublingual · ingredients NITROGLYCERIN 0.4 MG/ACT · company G pohl-boskamp gmbh & co kg · schedule Ethical
DIN 02231441: Nitrolingual Pump Spray
Raw flags: sec3=Y
Item: 241200069; group id 369; item number 0869; lccId None; manufacturer id SAV
Source form: Spray-200 Dose Pk; strength: 0.4mg/Metered Dose
Recorded listing: General benefit
Source prices (unrounded): $16.0000; ministry $8.4200
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02231441
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=50758Interchangeable products
Rho-Nitro Pumpspray · DIN 02238998 · $8.4200
Shortage status: resolved shortage (ended June 14, 2024); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02231441
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
1 brand, same coverage
Rho-Nitro Pumpspray · DIN 02238998
Manufacturer: Sandoz Canada Inc.; listing date 2014-06-26
Health Canada: Marketed since 2011-02-26 · brand RHO-NITRO PUMPSPRAY · ATC C01DA02 GLYCERYL TRINITRATE · form Metered-dose pump · route Sublingual · ingredients NITROGLYCERIN 0.4 MG/ACT · company Sandoz canada incorporated · schedule Ethical
Rho-Nitro Pumpspray: Formulary list price $8.42 per unit (the source does not state the unit; exact figure $8.4200). What the ministry pays, not the patient.
DIN 02238998: Rho-Nitro Pumpspray
Raw flags: sec3=Y
Item: 241200069; group id 369; item number 0869; lccId None; manufacturer id SDZ
Source form: Spray-200 Dose Pk; strength: 0.4mg/Metered Dose
Recorded listing: General benefit
Source prices (unrounded): $8.4200; ministry $8.4200
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02238998
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=62447Interchangeable products
Nitrolingual Pump Spray · DIN 02231441 · $8.4200
Shortage status: To be discontinued; reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02238998
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
1 brand, same coverage
Mylan-Nitro 0.4 · DIN 02407450
Manufacturer: Mylan Pharmaceuticals ULC; listing date 2013-11-28
Health Canada: Marketed since 2013-06-04 · brand MYLAN-NITRO PATCH 0.4 · ATC C01DA02 GLYCERYL TRINITRATE · form Patch (extended-release) · route Transdermal · ingredients NITROGLYCERIN 0.4 MG/HOUR · company Mylan pharmaceuticals ulc · schedule Ethical
Mylan-Nitro 0.4: Formulary list price $0.50 per unit (the source does not state the unit; exact figure $0.5040). What the ministry pays, not the patient.
DIN 02407450: Mylan-Nitro 0.4
Raw flags: sec3=Y
Item: 241200071; group id 369; item number 0871; lccId None; manufacturer id MYL
Source form: Transdermal Patch; strength: 0.4mg/Hr
Recorded listing: General benefit
Source prices (unrounded): $0.5040; ministry $0.5040
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02407450
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=89214Interchangeable products
Nitro-Dur · DIN 01911902 · $0.5040
Shortage status: resolved shortage (ended August 14, 2017); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02407450
Shortage record checked October 6, 2026
Nitro-Dur · DIN 01911902 · 0.4 mg/Hr · Transdermal Patch
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
1 brand, same coverage
Nitro-Dur · DIN 01911902
Manufacturer: Dr. Reddy's Laboratories Inc.; listing date 1996-10-01
Health Canada: Marketed since 2018-07-12 · brand NITRO-DUR 0.4 · ATC C01DA02 GLYCERYL TRINITRATE · form Patch (extended-release) · route Transdermal · ingredients NITROGLYCERIN 0.4 MG/HOUR · company Uspharma ltd · schedule Ethical
DIN 01911902: Nitro-Dur
Raw flags: sec3=Y
Item: 241200071; group id 369; item number 0871; lccId None; manufacturer id DRR
Source form: Transdermal Patch; strength: 0.4mg/Hr
Recorded listing: General benefit
Source prices (unrounded): $0.5040; ministry $0.5040
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=01911902
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=11225Interchangeable products
Mylan-Nitro 0.4 · DIN 02407450 · $0.5040
Shortage status: resolved shortage (ended February 10, 2023); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=01911902
Shortage record checked October 6, 2026
Trinipatch 0.6 · DIN 02230734 · 0.6 mg/Hr/21 Sq Cm · Patch
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
No interchangeable product listed in the Ontario extract
Trinipatch 0.6 · DIN 02230734
Manufacturer: Knight Therapeutics Inc.; listing date 1999-04-15
Health Canada: Marketed since 2026-02-03 · brand TRINIPATCH 0.6 · ATC C01DA02 GLYCERYL TRINITRATE · form Patch · route Transdermal · ingredients NITROGLYCERIN 0.6 MG/HOUR · company Knight therapeutics inc. · schedule Ethical
Trinipatch 0.6: Formulary list price $0.90 per unit (the source does not state the unit; exact figure $0.8950). What the ministry pays, not the patient.
DIN 02230734: Trinipatch 0.6
Raw flags: sec3=Y
Item: 241200068; group id 369; item number 0863; lccId None; manufacturer id KNT
Source form: Patch; strength: 0.6mg/Hr/21 Sq Cm
Recorded listing: General benefit
Source prices (unrounded): $0.8950; ministry $0.8950
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02230734
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=49996
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02230734
Shortage record checked October 6, 2026
Nitrostat · DIN 00037621 · 0.6 mg · SL tablet
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
No interchangeable product listed in the Ontario extract
Nitrostat · DIN 00037621
Manufacturer: Upjohn Canada ULC; listing date 1996-10-01
Health Canada: Marketed since 2023-08-03 · brand NITROSTAT · ATC C01DA02 GLYCERYL TRINITRATE · form Tablet · route Sublingual · ingredients NITROGLYCERIN 0.6 MG · company Bgp pharma ulc · schedule Ethical
DIN 00037621: Nitrostat
Raw flags: sec3=Y, selfMed=Y
Item: 241200003; group id 369; item number 0865; lccId None; manufacturer id UJC
Source form: SL Tab; strength: 0.6mg
Recorded listing: General benefit; self-medication (OTC-type) product
Source prices (unrounded): $0.1888; ministry $0.1888
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00037621
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=1253
Shortage status: active shortage (reported September 1, 2026, estimated to end October 20, 2026, last updated September 29, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=00037621
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
1 brand, same coverage
Mylan-Nitro 0.6 · DIN 02407469
Manufacturer: Mylan Pharmaceuticals ULC; listing date 2013-11-28
Health Canada: Marketed since 2013-06-04 · brand MYLAN-NITRO PATCH 0.6 · ATC C01DA02 GLYCERYL TRINITRATE · form Patch (extended-release) · route Transdermal · ingredients NITROGLYCERIN 0.6 MG/HOUR · company Mylan pharmaceuticals ulc · schedule Ethical
Mylan-Nitro 0.6: Formulary list price $0.50 per unit (the source does not state the unit; exact figure $0.5040). What the ministry pays, not the patient.
DIN 02407469: Mylan-Nitro 0.6
Raw flags: sec3=Y
Item: 241200072; group id 369; item number 0872; lccId None; manufacturer id MYL
Source form: Transdermal Patch; strength: 0.6mg/Hr
Recorded listing: General benefit
Source prices (unrounded): $0.5040; ministry $0.5040
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02407469
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=89215Interchangeable products
Nitro-Dur · DIN 01911929 · $0.5040
Shortage status: avoided shortage; reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02407469
Shortage record checked October 6, 2026
Nitro-Dur · DIN 01911929 · 0.6 mg/Hr · Transdermal Patch
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
1 brand, same coverage
Nitro-Dur · DIN 01911929
Manufacturer: Dr. Reddy's Laboratories Inc.; listing date 1996-10-01
Health Canada: Marketed since 2018-07-12 · brand NITRO-DUR 0.6 · ATC C01DA02 GLYCERYL TRINITRATE · form Patch (extended-release) · route Transdermal · ingredients NITROGLYCERIN 0.6 MG/HOUR · company Uspharma ltd · schedule Ethical
DIN 01911929: Nitro-Dur
Raw flags: sec3=Y
Item: 241200072; group id 369; item number 0872; lccId None; manufacturer id DRR
Source form: Transdermal Patch; strength: 0.6mg/Hr
Recorded listing: General benefit
Source prices (unrounded): $0.5040; ministry $0.5040
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=01911929
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=11226Interchangeable products
Mylan-Nitro 0.6 · DIN 02407469 · $0.5040
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=01911929
DIN 02407442: Mylan-Nitro 0.2
Raw flags: notABenefit=Y, sec3=Y, sec3b=Y
Item: 241200033; group id 369; item number 0870; lccId None; manufacturer id MYL
Source form: Transdermal Patch; strength: 0.2mg/Hr
Recorded listing: Off-Formulary Interchangeable, not an ODB benefit
Source prices (unrounded): $0.4687; ministry not recorded
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02407442
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=89213Interchangeable products
Nitro-Dur 0.2 · DIN 01911910 · not recorded
Shortage status: resolved shortage (ended October 18, 2017); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02407442
Nitro-Dur 0.2: Formulary list price None per unit (the source does not state the unit; exact figure not recorded). What the ministry pays, not the patient.
DIN 01911910: Nitro-Dur 0.2
Raw flags: notABenefit=Y, sec3=Y, sec3b=Y
Item: 241200033; group id 369; item number 0870; lccId None; manufacturer id DRR
Source form: Transdermal Patch; strength: 0.2mg/Hr
Recorded listing: Off-Formulary Interchangeable, not an ODB benefit
Source prices (unrounded): not recorded; ministry not recorded
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=01911910
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=11227Interchangeable products
Mylan-Nitro 0.2 · DIN 02407442 · not recorded
Shortage status: resolved shortage (ended February 3, 2023); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=01911910
DIN 02407477: Mylan-Nitro 0.8
Raw flags: notABenefit=Y, sec3=Y, sec3b=Y
Item: 241200058; group id 369; item number 0873; lccId None; manufacturer id MYL
Source form: Transdermal Patch; strength: 0.8mg/Hr
Recorded listing: Off-Formulary Interchangeable, not an ODB benefit
Source prices (unrounded): $0.9559; ministry not recorded
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02407477
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=89216Interchangeable products
Nitro-Dur 0.8 · DIN 02011271 · not recorded
Shortage status: resolved shortage (ended June 7, 2017); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02407477
Nitro-Dur 0.8: Formulary list price None per unit (the source does not state the unit; exact figure not recorded). What the ministry pays, not the patient.
DIN 02011271: Nitro-Dur 0.8
Raw flags: notABenefit=Y, sec3=Y, sec3b=Y
Item: 241200058; group id 369; item number 0873; lccId None; manufacturer id DRR
Source form: Transdermal Patch; strength: 0.8mg/Hr
Recorded listing: Off-Formulary Interchangeable, not an ODB benefit
Source prices (unrounded): not recorded; ministry not recorded
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02011271
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=14742Interchangeable products
Mylan-Nitro 0.8 · DIN 02407477 · not recorded
Shortage status: resolved shortage (ended February 3, 2023); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02011271
Temporary benefitOntario PIN; no Health Canada record under this code
StatusTemporary benefit
Write on scriptcheck temporary-benefit rules below
Patient paysNot paid by ODB 65 and over; see alternatives
No Health Canada record under this code: Ontario lists it under a product identification number (PIN), not a DIN.
Health Canada record for this brand: DIN 02231441 (Marketed, 2026-07-16)
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=50758
Nitrolingual Pumpspray · DIN 09858317
Manufacturer: Juno Pharmaceuticals Corp.; listing date 2023-11-30
No Health Canada record under this code: Ontario lists it under a product identification number (PIN), not a DIN.
Health Canada record for this brand: DIN 02231441 (Marketed, 2026-07-16)
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=50758
Nitrolingual Pumpspray: Formulary list price $8.42 per unit (the source does not state the unit; exact figure $8.4200). What the ministry pays, not the patient.
DIN 09858317: Nitrolingual Pumpspray
Raw flags: sec3c=Y
Item: 241200111; group id 369; item number 0866; lccId None; manufacturer id JUN
Source form: Sp-180 Dose Pk; strength: 0.4mg/Metered Dose
Recorded listing: Temporary benefit (shortage substitute)
Source prices (unrounded): $8.4200; ministry $8.4200
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=09858317
Health Canada record for this brand: DIN 02231441 (Marketed, July 16, 2026)
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=50758
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=09858317
Temporary benefitOntario PIN; no Health Canada record under this code
StatusTemporary benefit
Write on scriptcheck temporary-benefit rules below
Patient paysNot paid by ODB 65 and over; see alternatives
No Health Canada record under this code: Ontario lists it under a product identification number (PIN), not a DIN.
Health Canada record for this brand: DIN 02231441 (Marketed, 2026-07-16)
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=50758
Nitrolingual Pumpspray · DIN 09858327
Manufacturer: Sanofi-Aventis Canada Inc.; listing date 2024-01-31
No Health Canada record under this code: Ontario lists it under a product identification number (PIN), not a DIN.
Health Canada record for this brand: DIN 02231441 (Marketed, 2026-07-16)
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=50758
Nitrolingual Pumpspray: Formulary list price $9.40 per unit (the source does not state the unit; exact figure $9.4000). What the ministry pays, not the patient.
DIN 09858327: Nitrolingual Pumpspray
Raw flags: sec3c=Y
Item: 241200112; group id 369; item number 0867; lccId None; manufacturer id SAC
Source form: Sp-75 Dose Pk; strength: 0.4mg/Metered Dose
Recorded listing: Temporary benefit (shortage substitute)
Source prices (unrounded): $9.4000; ministry $9.4000
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=09858327
Health Canada record for this brand: DIN 02231441 (Marketed, July 16, 2026)
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=50758
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=09858327
Shortage record checked October 6, 2026
Transderm-Nitro · DIN 00852384 · 0.4 mg/Hr/20 Sq Cm · Patch
General benefit; Health Canada lists this DIN as Cancelled post market since 2022-04-05 — choose a marketed DIN from the same-category list.Discontinued April 5, 2022 · checked October 5, 2026
StatusGeneral benefit; Health Canada lists this DIN as Cancelled post market since 2022-04-05 — choose a marketed DIN from the same-category list.
Write on scriptno code needed; Health Canada lists this DIN as Cancelled post market since 2022-04-05 — choose a marketed DIN from the same-category list.
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
No interchangeable product listed in the Ontario extract
Transderm-Nitro · DIN 00852384
Manufacturer: Novartis Pharma Canada Inc.; listing date 1996-12-19
Health Canada: Cancelled post market since 2022-04-05 · brand TRANSDERM-NITRO 0.4 · ATC C01DA02 GLYCERYL TRINITRATE · form Patch (extended-release) · route Transdermal · ingredients NITROGLYCERIN 0.4 MG/HOUR · company Novartis pharmaceuticals canada inc · schedule Ethical
Transderm-Nitro: Formulary list price $1.00 per unit (the source does not state the unit; exact figure $1.0010). What the ministry pays, not the patient.
DIN 00852384: Transderm-Nitro
Raw flags: sec3=Y
Item: 241200034; group id 369; item number 0860; lccId None; manufacturer id NOV
Source form: Patch; strength: 0.4mg/Hr/20 Sq Cm
Recorded listing: General benefit
Source prices (unrounded): $1.0010; ministry $1.0010
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00852384
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=10116
Shortage status: discontinued (October 31, 2020, reported by NOVARTIS PHARMACEUTICALS CANADA INC); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=00852384
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since April 5, 2022 — choose a marketed DIN from the same-category list.
General benefit; Health Canada lists this DIN as Cancelled post market since 2024-05-01 — choose a marketed DIN from the same-category list.Discontinued May 1, 2024 · checked October 5, 2026
StatusGeneral benefit; Health Canada lists this DIN as Cancelled post market since 2024-05-01 — choose a marketed DIN from the same-category list.
Write on scriptno code needed; Health Canada lists this DIN as Cancelled post market since 2024-05-01 — choose a marketed DIN from the same-category list.
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
1 brand, same coverage
Mylan-Nitro Sublingual Spray · DIN 02243588
Manufacturer: Mylan Pharmaceuticals ULC; listing date 2003-01-30
Health Canada: Cancelled post market since 2024-05-01 · brand MYLAN-NITRO SUBLINGUAL SPRAY · ATC C01DA02 GLYCERYL TRINITRATE · form Metered-dose aerosol · route Sublingual · ingredients NITROGLYCERIN 0.4 MG/ACT · company Mylan pharmaceuticals ulc · schedule Ethical
Mylan-Nitro Sublingual Spray: Formulary list price $8.46 per unit (the source does not state the unit; exact figure $8.4600). What the ministry pays, not the patient.
DIN 02243588: Mylan-Nitro Sublingual Spray
Raw flags: sec3=Y
Item: 241200017; group id 369; item number 0868; lccId None; manufacturer id MYL
Source form: Spray-200 Dose Pk; strength: 0.4mg/Metered Dose
Recorded listing: General benefit
Source prices (unrounded): $8.4600; ministry $8.4600
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02243588
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=67506Interchangeable products
Nitrolingual · DIN 01926721 · not recorded
Shortage status: discontinued (May 1, 2024, reported by MYLAN PHARMACEUTICALS ULC); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02243588
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since May 1, 2024 — choose a marketed DIN from the same-category list.
Transderm-Nitro · DIN 02046156 · 0.6 mg/Hr/30 Sq Cm · Patch
General benefit; Health Canada lists this DIN as Cancelled post market since 2022-04-05 — choose a marketed DIN from the same-category list.Discontinued April 5, 2022 · checked October 5, 2026
StatusGeneral benefit; Health Canada lists this DIN as Cancelled post market since 2022-04-05 — choose a marketed DIN from the same-category list.
Write on scriptno code needed; Health Canada lists this DIN as Cancelled post market since 2022-04-05 — choose a marketed DIN from the same-category list.
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
No interchangeable product listed in the Ontario extract
Transderm-Nitro · DIN 02046156
Manufacturer: Novartis Pharma Canada Inc.; listing date 1997-04-10
Health Canada: Cancelled post market since 2022-04-05 · brand TRANSDERM-NITRO 0.6 · ATC C01DA02 GLYCERYL TRINITRATE · form Patch (extended-release) · route Transdermal · ingredients NITROGLYCERIN 0.6 MG/HOUR · company Novartis pharmaceuticals canada inc · schedule Ethical
Transderm-Nitro: Formulary list price $1.03 per unit (the source does not state the unit; exact figure $1.0290). What the ministry pays, not the patient.
DIN 02046156: Transderm-Nitro
Raw flags: sec3=Y
Item: 241200059; group id 369; item number 0861; lccId None; manufacturer id NOV
Source form: Patch; strength: 0.6mg/Hr/30 Sq Cm
Recorded listing: General benefit
Source prices (unrounded): $1.0290; ministry $1.0290
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02046156
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=15572
Shortage status: discontinued (September 2, 2021, reported by NOVARTIS PHARMACEUTICALS CANADA INC); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02046156
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since April 5, 2022 — choose a marketed DIN from the same-category list.
Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2001-07-20 — choose a marketed DIN from the same-category list.Discontinued July 20, 2001 · checked October 5, 2026
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2001-07-20 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record (an EAP request with clinical rationale is still possible); see alternatives; Health Canada lists this DIN as Cancelled post market since 2001-07-20 — choose a marketed DIN from the same-category list.
Patient paysNot paid by ODB 65 and over; see alternatives
1 brand, same coverage
Nitrolingual · DIN 01926721
Manufacturer: Aventis Pharma; listing date 1996-10-01
Health Canada: Cancelled post market since 2001-07-20 · brand NITROLINGUAL SPRAY 0.4MG/EAM · ATC C01DA02 GLYCERYL TRINITRATE · form Metered-dose aerosol · route Sublingual · ingredients NITROGLYCERIN 0.4 MG/ACT · company Aventis pharma inc · schedule Ethical
Nitrolingual: Formulary list price None per unit (the source does not state the unit; exact figure not recorded). What the ministry pays, not the patient.
DIN 01926721: Nitrolingual
Raw flags: notABenefit=Y, sec3=Y
Item: 241200017; group id 369; item number 0868; lccId None; manufacturer id AVE
Source form: Spray-200 Dose Pk; strength: 0.4mg/Metered Dose
Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category
Source prices (unrounded): not recorded; ministry not recorded
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=01926721
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=13160Interchangeable products
Mylan-Nitro Sublingual Spray · DIN 02243588 · $8.4600
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=01926721
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since July 20, 2001 — choose a marketed DIN from the same-category list.
Other products in the same Health Canada class (C01D, C01DA): coverage varies; not interchangeable
Isosorbide dinitrate (Isdn): general benefit, not a benefit
Isosorbide + mononitrate (Imdur): not a benefit
Vericiguat (Verquvo): limited Use 685
Other drugs in the same formulary class (24:12 Vasodilating Drugs) and how they are covered
Matched class: 24:12 Vasodilating Drugs
Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment.
Public program routes: ODB 65 and over
Some products covered without a code (check the product listing): ISOSORBIDE DINITRATE
24:12 Vasodilating Drugs
· 73 products · Off-Formulary Interchangeable, not an ODB benefit (72), Off-Formulary Interchangeable, not an ODB benefit; DIN status E (meaning unconfirmed); confirm discontinuation/availability with Health Canada (1) · strengths: 2.5mg, 5mg, 10mg, 20mg · Tab
INDICATIONS AND CLINICAL USE
NITROSTAT (nitroglycerin sublingual tablets) are indicated for the acute relief of an attack or
acute prophylaxis of angina pectoris due to coronary artery disease.
https://pdf.hres.ca/dpd_pm/00070110.PDF
PM date: March 27, 2023
Source product: NITROSTAT; DIN 00037613; fetched 2026-09-10
Product monograph posted by Health Canada; excerpt for lookup only.
Availability
Rho-Nitro Pumpspray · DIN 02238998
Shortage status: To be discontinued; reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02238998
Nitrostat · DIN 00037621
Shortage status: active shortage (reported 2026-09-01, estimated to end 2026-10-20, last updated 2026-09-29); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=00037621
Public program routes (Ontario context; residency, health-card/OHIP requirements and enrolment must be confirmed from the quoted rules):
ODB 65 and over (seniors path)
Eligibility: You may qualify for the Ontario Drug Benefit (ODB) program when you turn 65 years old. (ontario.ca, August 18, 2026 ↗)
Eligibility: The Ontario Drug Benefit program is for Ontario residents only and prescriptions must be filled in an Ontario pharmacy to be covered. (ontario.ca, August 18, 2026 ↗)
Eligibility: Individual annual net income threshold
Program year August 1, 2026 to July 31, 2027: $25,480
This applies to a senior who:
does not have a spouse
has a married spouse with whom they no longer live in a conjugal relationship
has a spouse living in a long-term care home or community home for opportunity (ontario.ca, July 2, 2026 ↗)
Eligibility: Combined annual net income requirement
Program year August 1, 2026 to July 31, 2027: $42,290
This applies to a senior who has a spouse, other than a spouse described. (ontario.ca, July 2, 2026 ↗)
Eligibility: See the first-year deductible table. (ontario.ca, August 18, 2026 ↗)
What it pays / costs: the first $100 of total prescription costs each program year (August 1 to July 31 the following year) (ontario.ca, August 18, 2026 ↗)
What it pays / costs: up to $6.11 for each prescription filled or refilled (after paying the deductible) (ontario.ca, August 18, 2026 ↗)
What it pays / costs: Seniors enrolled in the Seniors Co-Payment Program have no annual deductible and a reduced co-payment of up to $2. (ontario.ca, August 18, 2026 ↗)
Enrolment: "We will send you a letter about 3 months before your 65th birthday to let you know you will automatically join the Ontario Drug Benefit program on the first day of the month after you turn 65 years old." (ontario.ca, August 18, 2026 ↗)
Enrolment: "To enroll in the Seniors Co-Payment Program, a senior must submit an application to that program and qualify under certain income eligibility thresholds." (ontario.ca, August 18, 2026 ↗)
First year on ODB? The deductible depends on birth month
For your first year of Ontario Drug Benefit program eligibility, depending on the month you turn 65, the deductible may be lower than $100.
That’s because the amount of the deductible is based on the number of months between your official start date (the first day of the month after you turn 65) and July 31 (the last day of the Ontario Drug Benefit program year).
For example, if you turned 65 on April 15, your official start date would be May 1. Counting from May 1 to July 31 your deductible for the first year would be $25.
Use this chart below to see what the deductible will be in your first year:
For Mylan-Nitro 0.2, Nitro-Dur 0.2, Mylan-Nitro 0.8, Nitro-Dur 0.8, Nitrolingual: no applicable EAP criteria are held and no ODB benefit is established. These policies do not establish coverage.
For rare, immediately life-, limb- or organ-threatening circumstances, the Compassionate Review Policy may consider an unfunded drug or indication, subject to its criteria and without bypassing the drug review process. Compassionate Review Policy
Compassionate Review Policy: source quote
Where there are rare clinical circumstances in immediately life, limb, or organ-threatening conditions, the Executive Officer will also consider requests for drugs or indications in situations where there has not been a decision by the Executive Officer to provide funding of the drug or indication as part of the Ontario Drug Benefit program (and the EAP), and the drug or indication requested would not circumvent the established review process for new drugs or indications as part of the drug submission process for listing within the Ontario Drug Benefit program. Requests must meet the criteria for the Compassionate Review Policy.
For cancer drugs, Case-by-Case Review considers rare, immediately life-threatening circumstances when no satisfactory funded treatment exists; its criteria and application process apply. Case-by-Case Review (cancer drugs)
Case-by-Case Review (cancer drugs): source quote
Note: Requests for cancer drugs are considered under the Case-by-Case Review Program (CBCRP) which is administered by Ontario Health (Cancer Care Ontario) on behalf of the Ministry of Health. The CBCRP considers funding requests for drugs (both oral therapies and injectable drugs) for the treatment of cancer in patients who have a rare clinical circumstance that is immediately life-threatening (death is likely within a matter of months) and who require treatment with an unfunded drug, because there is no other satisfactory and funded treatment. Please refer to the Ontario Health website for information on the application process, FAQs, eligibility criteria and program policies.